Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer
暂无分享,去创建一个
R. Fodde | H. Snippert | J. Laoukili | O. Kranenburg | S. Nierkens | S. Elias | I. B. Rinkes | M. Gloerich | E. Strating | Susanne J van Schelven | J. Roodhart | Mathijs Verhagen | Ester Dünnebach | Liza A. Wijler | Mirjam C van der Net | N. A. Peters | E. Wensink | Joris H. Hageman | Itziar Aranguren | Alberto Sanchez De la Cruz | I. Rinkes
[1] A. Mariotto,et al. Estimation of the numbers of individuals living with metastatic cancer in the United States. , 2022, Journal of the National Cancer Institute.
[2] Annelisa M Cornel,et al. Uncovering the mode of action of engineered T cells in patient cancer organoids , 2022, Nature Biotechnology.
[3] S. Prabhakar,et al. Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer , 2022, Nature Genetics.
[4] P. Gibbs,et al. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. , 2022, The Lancet. Oncology.
[5] S. Terry,et al. The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes? , 2022, Frontiers in Immunology.
[6] G. Curigliano,et al. Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers , 2022, Journal for ImmunoTherapy of Cancer.
[7] Qiang Yu,et al. Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling , 2021, Cell Death & Disease.
[8] C. Rudin,et al. Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity. , 2021, Cancer cell.
[9] P. Sharma,et al. The Next Decade of Immune Checkpoint Therapy. , 2021, Cancer discovery.
[10] A. Kundaje,et al. Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer , 2021, Nature Genetics.
[11] Heming Ge,et al. Extracellular Matrix Stiffness: New Areas Affecting Cell Metabolism , 2021, Frontiers in Oncology.
[12] D. Schrag,et al. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. , 2021, JAMA.
[13] R. Brekken,et al. Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer , 2021, bioRxiv.
[14] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[15] Teruhiko Yoshida,et al. Re-expression of REG family and DUOXs genes in CRC organoids by co-culturing with CAFs , 2021, Scientific reports.
[16] P. Gibbs,et al. Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer. , 2020, The New England journal of medicine.
[17] J. Bluestone,et al. Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis , 2020, Science Immunology.
[18] R. Piñeiro,et al. Dangerous Liaisons: Circulating Tumor Cells (CTCs) and Cancer-Associated Fibroblasts (CAFs) , 2020, Cancers.
[19] J. Galon,et al. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy , 2020, Nature Reviews Cancer.
[20] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[21] H. Verheul,et al. Combinatorial Immunotherapies for Metastatic Colorectal Cancer , 2020, Cancers.
[22] Shannon M. Mumenthaler,et al. Anti-EGFR Therapy Induces EGF Secretion by Cancer-Associated Fibroblasts to Confer Colorectal Cancer Chemoresistance , 2020, Cancers.
[23] D. Tuveson,et al. DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS. , 2020, Physiological reviews.
[24] Y. Cho,et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer , 2020, Nature Genetics.
[25] K. Tarte,et al. Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. , 2020, Cancer discovery.
[26] E. Puré,et al. Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy , 2020, Current opinion in immunology.
[27] Y. Kluger,et al. Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche , 2020, Nature.
[28] M. Kreutz,et al. The immunological Warburg effect: Can a metabolic‐tumor‐stroma score (MeTS) guide cancer immunotherapy? , 2020, Immunological reviews.
[29] Jun Yu,et al. Organoid models of gastrointestinal cancers in basic and translational research , 2020, Nature Reviews Gastroenterology & Hepatology.
[30] Joseph Willson. Stress fibres fuel glycolysis , 2020, Nature Reviews Molecular Cell Biology.
[31] P. Sharma,et al. Dissecting the mechanisms of immune checkpoint therapy , 2020, Nature Reviews Immunology.
[32] Marieke E. Ijsselsteijn,et al. Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4 , 2019, Genome Medicine.
[33] M. Emberton,et al. Cancer-associated fibroblasts mediate cancer progression and remodel the tumouroid stroma , 2019, British Journal of Cancer.
[34] P. Sharma,et al. Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy , 2019, Cell.
[35] R. Fodde,et al. Cell Heterogeneity and Phenotypic Plasticity in Metastasis Formation: The Case of Colon Cancer , 2019, Cancers.
[36] N. Cho,et al. Compression-induced expression of glycolysis genes in CAFs correlates with EMT and angiogenesis gene expression in breast cancer , 2019, Communications Biology.
[37] N. Erez,et al. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment , 2019, Front. Immunol..
[38] Hans Clevers,et al. Cancer modeling meets human organoid technology , 2019, Science.
[39] Z. Stadler,et al. Immunotherapy in colorectal cancer: rationale, challenges and potential , 2019, Nature Reviews Gastroenterology & Hepatology.
[40] Subha Madhavan,et al. Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities , 2019, Cell.
[41] R. Satija,et al. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression , 2019, Genome Biology.
[42] Xinxia Peng,et al. Circulating tumor cells exit circulation while maintaining multicellularity, augmenting metastatic potential , 2019, Journal of Cell Science.
[43] L. Grøntved,et al. Collagen density regulates the activity of tumor-infiltrating T cells , 2018, Journal of Immunotherapy for Cancer.
[44] M. Najafi,et al. Extracellular matrix (ECM) stiffness and degradation as cancer drivers , 2018, Journal of cellular biochemistry.
[45] E. Batlle,et al. 8 TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis , 2018, ESMO Open.
[46] F. Marincola,et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study , 2018, The Lancet.
[47] H. Clevers,et al. Organoids in cancer research , 2018, Nature Reviews Cancer.
[48] Paul Hoffman,et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.
[49] H. Yao,et al. CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness , 2018, Cell.
[50] M. Sawyer,et al. Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] A. van Oudenaarden,et al. Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations , 2017, Nature Methods.
[52] U. Martinez-outschoorn,et al. Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development. , 2017, Seminars in oncology.
[53] C. Punt,et al. From tumour heterogeneity to advances in precision treatment of colorectal cancer , 2017, Nature Reviews Clinical Oncology.
[54] Hans Clevers,et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer , 2017, The Journal of experimental medicine.
[55] I. Mellman,et al. Elements of cancer immunity and the cancer–immune set point , 2017, Nature.
[56] Peter Bankhead,et al. QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.
[57] S. Haferkamp,et al. LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells. , 2016, Cell metabolism.
[58] Mauro J. Muraro,et al. A Single-Cell Transcriptome Atlas of the Human Pancreas , 2016, Cell systems.
[59] Toshio Uraoka,et al. A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis. , 2016, Cell stem cell.
[60] Shuqiang Li,et al. CEL-Seq2: sensitive highly-multiplexed single-cell RNA-Seq , 2016, Genome Biology.
[61] Etienne Becht,et al. Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy , 2016, Clinical Cancer Research.
[62] Jeffrey S. Morris,et al. The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.
[63] Bert Vogelstein,et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.
[64] Hayley E. Francies,et al. Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients , 2015, Cell.
[65] G. Inghirami,et al. Stromal contribution to the colorectal cancer transcriptome , 2015, Nature Genetics.
[66] Camille Stephan-Otto Attolini,et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.
[67] Jeffrey R. Whiteaker,et al. Proteogenomic characterization of human colon and rectal cancer , 2014, Nature.
[68] A. Oudenaarden,et al. Validation of noise models for single-cell transcriptomics , 2014, Nature Methods.
[69] P. Jung,et al. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. , 2012, Cancer cell.
[70] Wayne W. Hancock,et al. Substrate Rigidity Regulates Human T Cell Activation and Proliferation , 2012, The Journal of Immunology.
[71] C. Haslinger,et al. Modeling colon adenocarcinomas in vitro a 3D co-culture system induces cancer-relevant pathways upon tumor cell and stromal fibroblast interaction. , 2011, The American journal of pathology.
[72] W. Huber,et al. which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .
[73] P. Fortina,et al. The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma , 2009, Cell cycle.
[74] Jiannis Ragoussis,et al. Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts , 2009, The Journal of Biological Chemistry.
[75] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[76] P. Friedl,et al. Mechanoreciprocity in cell migration , 2017, Nature Cell Biology.
[77] Robert C. Wolpert,et al. A Review of the , 1985 .